Ascendis Pharma A/S (NASDAQ:ASND) reported earnings of ($1.04) per share missing Walls Streets expectations.

Ascendis Pharma A/S (NASDAQ:ASND) reported 6/30/2017 earnings this Afternoon, coming in at ($1.04) per share, missing Wall Street’s estimates of ($0.80) per Share. Revenue for the quarter came in at $0.44 million missing the streets estimates of $0.78 million

Story continues below

Analyst Coverage For Ascendis Pharma A/S (NASDAQ:ASND)
These are 1 Hold Rating, 3 Buy Ratings .
The current consensus rating for Ascendis Pharma A/S (NASDAQ:ASND) is Buy (Score: 2.75) with a consensus target price of $31.00 , a potential (11.11% upside)

      Recent Trading for Ascendis Pharma A/S (NASDAQ:ASND)
      Shares of Ascendis Pharma A/S closed the previous trading session at 27.90 down -0.10 -0.36% with 38,685 shares trading hands.

      An ad to help with our costs